Clinical Effects and Mechanism of 3D Laparoscopic Sleeve Gastrectomy in Treatment of Obesity Combined with Type 2 Diabetes Mellitus
Wang Bo,Wang Danwen,Xi Yiqing,Yang Lijie,Yang Zhangshuo,Feng Maohui,Ma Dandan,Fu Tao,Cai Xun
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.12.042
2018-01-01
Abstract:Objective To investigate the feasibility,safety and clinical effects of 3D laparoscopic sleeve gastrectomy (LSG) in treatment of obesity combined with type 2 diabetes mellitus (T2DM) and its impact on blood Ghrelin levels.Methods Clinical data of 26 patients who underwent 3D laparoscopicsleeve gastrectomy in our hospital between January 2016 and September 2017 were retrospectively collected.All the 26 patients were operated by the same surgical team.The patients were followed up for 1 year.The surgical and postoperative recovery situations,the effect of weight reduction,hypoglycemic effects,serum Ghrelin levels and glucagon like peptide 1 (GLP-1) were observed at 3rd,6th and 12th month after operation.Results The 3D LSG was performed successfully on 26 patients,without conversion to open surgery.There were no postoperative complications (anastomotic leak,bleeding and stenosis,etc) and perioperative death.Operation time,volume of intraoperative blood loss,time of out of bed,time of post-operative gastrointestinal function recovery and hospital stay were (60.00 ± 17.06) min,(7.31 ±2.54) nl,(1.58±0.50) days,(1.92±0.63) days,and (7.50±1.21) days,respectively.The numerical rating scale score was (3.42 ±0.50) and (1.42 ±0.50) respectively at 1st and 3rd day after operation.All 26 patients were followed up.As compared to pre-operation,the average body weight,BMI,waist circumference,hip circumference and waist-hip Ratio were all decreased at 3rd,6th and 12th month after operation (body weight:P=0.001,0.000,0.000;BMI:P=0.001,0.000,0.000;waist circumference:P=0.000,0.000,0.000;hip circumference:P=0.017,0.000,0.000;WHR:P=0.017,0.000,0.000).Meanwhile,as compared to pre-operation,the average fasting blood glucose (FBG),the fasting serum inculin (FINS),the fasting C-peptide (FCP) and the HbA1c were all reduced at 3rd,6th and 12th month after operation (FBG:P=0.000,0.000,0.000;FINS:P=0.000,0.000,0.000;FCP:P=0.002,0.000,0.000;HbA1c:P=0.000,0.000,0.000).The remission rate of T2DM at 12th month postoperatively was 92.31％,with an effective rate of 100.0％.Moreover,the serum Ghrelin levels were significantly decreased at 3rd,6th,and 12th month after operation as compared to pre-operation (P =0.000,0.000,0.000).Meanwhile,there was no statistically significant difference in GLP-1 (P =0.797,0.300,0.597).Conclusion The 3D LSG is safe and effective in the treatmentof obesity combined with T2DM,with a good short-term outcome.Moreover,the 3D LSG regulates and controls FBG by changing the level of Ghrelin.